| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 167.26B | 175.75B | 181.64B | 184.72B | 142.20B | 116.07B |
| Gross Profit | 28.36B | 33.51B | 36.09B | 38.15B | 27.85B | 19.61B |
| EBITDA | 13.55B | 13.57B | 15.85B | 20.22B | 12.48B | 6.72B |
| Net Income | 2.74B | 5.88B | 8.25B | 7.82B | 7.90B | 1.70B |
Balance Sheet | ||||||
| Total Assets | 197.39B | 192.58B | 206.94B | 192.34B | 170.11B | 156.01B |
| Cash, Cash Equivalents and Short-Term Investments | 28.29B | 25.62B | 29.49B | 25.67B | 18.30B | 20.81B |
| Total Debt | 24.77B | 26.25B | 35.99B | 33.81B | 25.56B | 25.88B |
| Total Liabilities | 78.26B | 78.77B | 93.09B | 90.98B | 75.45B | 66.74B |
| Stockholders Equity | 115.29B | 110.43B | 110.90B | 98.84B | 92.42B | 87.19B |
Cash Flow | ||||||
| Free Cash Flow | 5.76B | 7.70B | 4.04B | -164.00M | -2.63B | 1.17B |
| Operating Cash Flow | 12.50B | 18.35B | 16.32B | 9.19B | 5.26B | 7.09B |
| Investing Cash Flow | -7.01B | -8.36B | -12.73B | -8.12B | -5.97B | -4.01B |
| Financing Cash Flow | -7.47B | -14.32B | -571.00M | 5.43B | -2.30B | -2.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥6.47T | 59.16 | 8.95% | 1.88% | 2.88% | 28.76% | |
70 Outperform | ¥35.10B | 10.46 | ― | 4.53% | -2.57% | 3.43% | |
67 Neutral | ¥3.88T | 15.03 | ― | 1.41% | 7.73% | -1.93% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥119.64B | 11.45 | ― | 2.18% | -0.93% | -45.03% | |
56 Neutral | ¥493.06B | 15.62 | ― | 2.57% | 4.81% | -49.43% | |
47 Neutral | ¥33.94B | 9.09 | 2.26% | ― | -2.53% | -85.61% |